Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature

Table 1

Demographic and histological profile of patients receiving rituximab ().

Parameter	Patients without R-ILD ()	Patients with R-ILD ()
Age (mean ± SD) years
Age > 45 years	5	5
Age < 45 years	5	1
Male : female	4 : 6	5 : 1
Histopathology
(1) DLBCL*	10	4
(2) Others**	0	2

Diffuse large B cell lymphoma, **mantle zone lymphoma, and follicular lymphoma.